FINAL PROGRAM

Monday, October 13, 2014

08:00 – 08:45 REGISTRATION
09.00 – 09.15 OPENING CEREMONY :
– Arrival of Mr. Chawat Arthayukti, Representative of Professor Dr.HRH Princess Chulabhorn
– Report by Dr. Enrico Mihich (Dana-Farber Cancer Institute, USA)
– Report by Mr.Hans-Peter Huber (Fritz Bender Foundation, Germany)
– Opening Address by Mr. Chawat Arthayukti, Representative of Professor Dr. HRH Princess Chulabhorn
– Departure of Mr. Chawat Arthayukti, Representative of Professor Dr. HRH Princess Chulabhorn
Session I: Genetic Profiles of Cancer
Chairperson : Kurt S. Zänker (University of Witten/Herdecke, Germany)

09:15

Trans-ethnic landscape of hepatocellular carcinoma genome
– Tatsuhiro Shibata (National Cancer Center, Japan)

10:00

Towards integrated “omics” for personalized treatment of breast cancer
Anne-Lise Borresen-Dale (Institute for Cancer Research, Norwegian Radium Hospital,
Norway)
10:45 Break

11:15

Hypothesis based genomics as a tool to query clinically relevant essential biology in cancer – Zoltan Szallasi (Technical University of Denmark, Denmark)

12:00

The new driver-based classification of breast cancer: 10 distinct molecular entities
Carlos Caldas (Cambridge Research Institute, UK)
12:45 LUNCH
Session II: Therapeutic Targets and Drugs
Chairperson :
Enrico Mihich (Dana-Farber Cancer Institute, USA)

14:00

Development of targeted cancer therapies – Axel Ullrich (Max Planck Institute of
Biochemistry, Germany)
14:45 Recent successes in targeted anti-cancer therapy – Alex Matter (Experimental Therapeutics Centre, Singapore)
15:30 Break

16:00

Disrupting arginine metabolism with apoptotic inducing agents: A new paradigm in treating arginine dependent tumors – Niramol Savaraj (Sylvester Comprehensive Cancer Center, University of Miami, USA)

Tuesday, October 14, 2014

Session III: Experimental Therapeutics: Models
Chairperson : Lynn G. Feun (Sylvester Comprehensive Cancer Center, University of Miami, USA)

09:00

I don`t have time to write an essay so i have to buy essay right now on essay.coach, cause of their cheap and high quality essays.

09:45

The critical role of extracellular matrix and microenvironment in metastasis and dormancy – Mina Bissell (Lawrence Berkeley National Laboratory, USA)
10:30 Break

11:00

Precision oncology for colorectal cancers – Alberto Bardelli (University of Torino Medical School, Italy)

11:45

Tackling the heterogeneity of brain tumors – Joan Seoane (Vall d’Hebron University Hospital and Institute of Oncology, Spain)
12:30 LUNCH
Session IV: Tumor-Host Relationships
Chairperson : M.R. Jisnuson Svasti (Chulabhorn Research Institute, Thailand)

13:30

Remodeling of collagen architecture can mirror immunological changes of tissue
microenvironment: new insights for targeting treatments – Luca Vannucci (Academy of Science of the , Czech Republic, Czech Republic)

14:15

MHC antigens and the immune escape of cancer – Federico Garrido (Hospital Universitario Virgen de las Nieves, Spain)
15:00 Break

15:30

High HLA class I antigen expression in combination with low PD-L1 expression as a favourable prognostic biomarker in intrahepatic cholangiocarcinoma – Soldano Ferrone (Harvard Medical School, USA)
Session V: Translational Investigations
Chairperson : M.R. Jisnuson Svasti (Chulabhorn Research Institute, Thailand)

16:15

Precision cancer medicine at the Dana-Farber Cancer Institute – William C. Hahn (Dana-
Farber Cancer Institute, USA)

Wednesday, October 15, 2014

Session V: Translational Investigations (Continuation)
Chairperson : William W. Au (Shantou University Medical Collage, P.R. China)

09:00

Evolving strategies in cancer drug development: Changing the Phase I trial 
Bruce Chabner (Harvard Medical School, USA)

09:45

Novel therapies for hepatocellular carcinoma – Lynn G. Feun (Sylvester
Comprehensive Cancer Center, University of Miami, USA)
10:30 Break

11:00

Dissecting colorectal cancer in multiple targetable subtypes– Josep Tabernero
(Vall d’Hebron University Hospital and Institute of Oncology, Spain)

11:45

Use of mechanism-based evidence for the development of therapy for human cancers – William W. Au (Shantou University Medical College, P.R. China)

12:30

Cancer-related fatigue: Symptoms, diagnosis and therapy – Kurt S. Zänker (University of Witten/Herdecke, Germany)
13:15 LUNCH

14:15

Concluding Remarks:
– Kurt S. Zänker
(University of Witten/Herdecke, Germany)

 ———————————-